Alveo
Alameda, US · Founded 2015 · Delaware corporation · 5 known investors
Alveo Technologies develops molecular detection and diagnostics technology, offering an open platform to detect pathogens across multiple industry sectors and pathogen types, including applications spanning human and veterinary/zoonotic disease surveillance. The company operates in the in vitro diagnostics and medical device industry.
AgTechBiotechDigital HealthHealthtechMedical Devices
Founders & leadership
Alveo was founded in 2015 by Ron Chiarello.
RC
Ron ChiarelloFounder
MA
Michael AicherExecutive
SH
Shaun HoltChairman of the Board & Chief Executive Officer
ET
Erik Tyrrell-KnottPresident & Chief Business Officer
S
ScottChief Commercial Officer
SE
Slava ElaginExecutive (R&D/Operations)
M
MarcusSenior Vice President of Software Engineering
Board
IB
Isaac BlechBoard director
RS
Robin SteeleBoard director
LB
Lawrence BlattBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$63.6M disclosed across 2 rounds · 2016–2021
▶$16MraisedMar 2021 · 2 investors · BiotechnologyRule 506(b)
▶$16MraisedMar 2021 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ronald ChiarelloExecutive Officer, Director
- Robin SteeleDirector
- Lawrence BlattDirector
- Julianne AverillExecutive Officer
- Yuh-Min ChiangExecutive Officer
- Nicholas BrathwaiteDirector
- Offering amount
- $30.1M
- Amount sold
- $16M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$47.6MraisedFeb 2018 · 248 investors · BiotechnologyRule 506(b)
▶$47.6MraisedFeb 2018 · 248 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Isaac BlechDirector
- Robin SteeleDirector
- Michael AicherExecutive Officer, Director
- Ron ChiarelloExecutive Officer, Director
- Lawrence BlattDirector
- Offering amount
- $47.6M
- Amount sold
- $47.6M
- Sales commissions
- $3.1M
- Placement agents
- Maxim Group LLC
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Avalotx6 shared keywordsAvalo is a clinical-stage biotechnology company developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases. Its pipeline includes abdakibart (AVTX-009), tested in a Phase 2 trial for hidradenitis suppurativa, and AVTX-010, a long-acting next-generation anti-IL-1β antibody.
Labcorp5 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Alveolusbio5 shared keywordsAlveolus Bio is a biotech company developing therapeutics at the intersection of respiratory medicine, microbiome science, and drug delivery modalities. Its work is led by an interdisciplinary team of physicians and researchers focused on lung disease.
Companies competing with Alveo for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Alveo do?
- Alveo Technologies develops molecular detection and diagnostics technology, offering an open platform to detect pathogens across multiple industry sectors and pathogen types, including applications spanning human and veterinary/zoonotic disease surveillance. The company operates in the in vitro diagnostics and medical device industry.
- Who founded Alveo?
- Alveo was founded by Ron Chiarello in 2015.
- Who are Alveo's investors?
- Alveo's investors include Black Diamond Ventures, Celesta Capital, Civilization Ventures Management, Llc, Partners Resolute, SUPPLY CHANGE CAPITAL.
- How much funding has Alveo raised?
- Alveo has disclosed $63.6M raised across 2 rounds.
- Where is Alveo headquartered?
- Alveo is headquartered in Alameda, US.